Floatz logo

Anti-Cd19/20-Car Vector-Transduced T Cells

Microcalcification

University of ZurichCell therapyActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

3 Active assets in the Microcalcification cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
University of Zurich
D
Fludarabine
University of Zurich
D
Bendamustine
University of Zurich
D

Same molecule, other indications

Anti-Cd19/20-Car Vector-Transduced T Cells is also rated in:

B Cell LymphomaDormant
CCC
Indicative ·
53 / 100
View asset →
Hematopoietic/Lymphoid CancerDormant
CCC
Indicative ·
52 / 100
View asset →
Adult Acute Lymphoblastic Leukemia in RemissionDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →